Interferon Gamma for Drug Resistant Tuberculosis

NCT00001407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Pneumonia
Pulmonary Tuberculosis

Interventions

DRUG: Interferon Gamma

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)